MYBPHL
Basic information
Region (hg38): 1:109292365-109307011
Links
Phenotypes
GenCC
Source:
- familial dilated cardiomyopathy (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYBPHL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 33 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 17 | 17 | ||||
Total | 0 | 0 | 33 | 0 | 20 |
Variants in MYBPHL
This is a list of pathogenic ClinVar variants found in the MYBPHL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-109294170-G-C | Benign (May 13, 2021) | |||
1-109294213-A-G | Benign (May 13, 2021) | |||
1-109294220-C-G | Benign (May 13, 2021) | |||
1-109294929-A-G | Benign (May 13, 2021) | |||
1-109295086-G-A | Benign (May 21, 2021) | |||
1-109295125-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
1-109295161-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
1-109295188-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
1-109295219-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
1-109295494-C-T | Benign (May 13, 2021) | |||
1-109296211-T-C | Benign (May 13, 2021) | |||
1-109296296-C-T | Benign (May 04, 2021) | |||
1-109296323-C-T | not specified | Uncertain significance (Feb 11, 2022) | ||
1-109296338-G-A | Brugada syndrome | Uncertain significance (Mar 06, 2023) | ||
1-109296441-AT-A | Benign (May 13, 2021) | |||
1-109296441-A-AT | Benign (May 13, 2021) | |||
1-109296770-A-G | Benign (May 13, 2021) | |||
1-109296778-C-T | Benign (May 04, 2021) | |||
1-109296791-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
1-109296801-C-T | not specified | Uncertain significance (Jan 31, 2023) | ||
1-109296804-G-A | not specified | Uncertain significance (May 29, 2024) | ||
1-109296809-G-A | not specified | Uncertain significance (Dec 06, 2021) | ||
1-109296811-A-G | Benign (May 04, 2021) | |||
1-109296837-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-109296849-C-T | not specified | Uncertain significance (Oct 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYBPHL | protein_coding | protein_coding | ENST00000357155 | 8 | 14677 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00369 | 0.988 | 125365 | 0 | 383 | 125748 | 0.00152 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.404 | 205 | 222 | 0.924 | 0.0000135 | 2271 |
Missense in Polyphen | 54 | 70.093 | 0.7704 | 789 | ||
Synonymous | -0.417 | 95 | 90.0 | 1.06 | 0.00000559 | 743 |
Loss of Function | 2.32 | 7 | 17.5 | 0.401 | 8.29e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000572 | 0.000572 |
Ashkenazi Jewish | 0.00169 | 0.00169 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00314 | 0.00315 |
European (Non-Finnish) | 0.00212 | 0.00212 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.00101 | 0.00101 |
Other | 0.00163 | 0.00163 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.670
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.83
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.285
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.172
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mybphl
- Phenotype
- muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); endocrine/exocrine gland phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- biological_process
- Cellular component
- cellular_component
- Molecular function
- molecular_function;protein binding